- Home
- What We Do
- Investment Banking
- Transactions
Transactions
Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 80 transactions and raising C$6.1 billion on behalf of our clients in Q1/231.2.
Pending Completion
Biorez, Inc.
Financial Advisor (Sell side)
HEALTHCARE
M&A ADVISORY
US
View transaction detail
July 2022
Amplifire
Exclusive Financial Advisor to Amplifire, a Portfolio Company of Leeds Equity Partners, on its Acquisition by Polaris Growth Fund
HEALTHCARE
TECHNOLOGY
FINANCIAL SPONSORS
M&A ADVISORY
US
View transaction detail
July 2022
Stratasan
Financial Advisor to Stratasan on its Acquisition by Syntellis Performance Solutions, a Portfolio Company of Madison Dearborn Partners and Thoma Bravo
HEALTHCARE
M&A ADVISORY
FINANCIAL SPONSORS
US
View transaction detail
US$65m
June 2022
Oncolytics Biotech
Agent (ATM Offering)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
June 2022
Panbela Therapeutics
Exclusive Financial Advisor (Buy side)
HEALTHCARE
M&A ADVISORY
US
View transaction detail
US$112m
June 2022
Arcellx, Inc.
Joint Bookrunner (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
US$50m
June 2022
Cardiol Therapeutics
Lead Agent (ATM Offering)
HEALTHCARE
EQUITY CAPITAL MARKETS
CANADA
US
View transaction detail
May 2022
KemPharm, Inc.
Financial Advisor (Buy side)
HEALTHCARE
M&A ADVISORY
US
DENMARK
View transaction detail
US$40m
May 2022
HEXO Corp.
Agent (ATM Offering)
HEALTHCARE
EQUITY CAPITAL MARKETS
CANADA
US
View transaction detail
US$75m
May 2022
Zynerba Pharmaceuticals
Co-Agent (ATM Offering)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
US$130m
May 2022
Rezolute, Inc.
Co-Manager (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
RiteGene Technologies
April 2022
RiteGene Technologies
Exclusive Financial Advisor (Sell side)
HEALTHCARE
CANNABIS
M&A ADVISORY
US
View transaction detail
- Company information as of June 30, 2022
- Transactions valued above C$1.5 million
* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description
How can we help?
If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.